Which is more profitable, Merck KGaA or Roche?

Roche keeps more of every sale as profit.

Which grows faster, Merck KGaA or Roche?

Roche grew its sales faster in recent years.

Which is cheaper, Merck KGaA or Roche?

Merck KGaA costs less for each unit of yearly profit (lower P/E).

Which has less debt, Merck KGaA or Roche?

Roche would need fewer years of earnings to pay off its debt.

Merck KGaAMRK.DEvs

RocheRO.SW

Merck KGaA vs Roche stock

Side by side in plain words: who keeps more of its sales, grows faster, costs less and owes less.

In one sentence

Merck KGaA is cheaper for its profits. Roche is more profitable, grows faster and has less debt.

Side by side

	Merck KGaA	Roche
	€65.0 billion	CHF 328 billion
	12.4%	20.3%
	−1.7%	−1.3%
	24.9×	25.5×
	1.6 years	1.3 years
	6.4%	23.2%
	0.4%	2.4%

Open Merck KGaA Open Roche

How we compare

Four contests with the same rules as each stock page: profit kept from sales (higher wins), yearly sales growth across the last reports, up to five years (higher wins), price per unit of yearly profit (lower P/E wins; a company without profit loses) and debt in years of earnings (lower wins). A winner is only named when both companies have the number.

More comparisons: Merck KGaA vs AbbVie · Merck KGaA vs Johnson & Johnson · Merck KGaA vs Eli Lilly · Merck KGaA vs Merck & · Roche vs Moderna · Roche vs Novo Nordisk · Roche vs Novartis · Roche vs Pfizer